Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft Rejection”

518 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 518 results

Large-scale testing (Phase 3)Study completedNCT00000137
What this trial is testing

Collaborative Corneal Transplantation Studies (CCTS)

Who this might be right for
Corneal TransplantationGraft Rejection
National Eye Institute (NEI)
Not applicableStudy completedNCT03652402
What this trial is testing

Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN

Who this might be right for
Kidney Transplant RejectionKidney TransplantationRisk Stratification+1 more
Assistance Publique - Hôpitaux de Paris 558
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Large-scale testing (Phase 3)Looking for participantsNCT07412470
What this trial is testing

Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Sanofi 526
Testing effectiveness (Phase 2)Looking for participantsNCT07046910
What this trial is testing

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

Who this might be right for
Lung Transplant Rejection
University of Virginia 60
Testing effectiveness (Phase 2)Study completedNCT01873157
What this trial is testing

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Who this might be right for
Late Rejection of Renal TransplantAntibody-mediated Rejection
Medical University of Vienna 44
Not applicableEnded earlyNCT03780101
What this trial is testing

Pathology and Imaging in Kidney Allografts

Who this might be right for
Renal Transplant RejectionChronic Kidney DiseasesFibrosis
NHS Greater Glasgow and Clyde 29
Early research (Phase 1)Ended earlyNCT02012153
What this trial is testing

Mesenchymal Stromal Cells in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Mario Negri Institute for Pharmacological Research 3
Not applicableLooking for participantsNCT06314230
What this trial is testing

Australian Genomics Of Chronic Allograft Dysfunction Study

Who this might be right for
Kidney Transplant RejectionKidney Transplant; Complications
Western Sydney Local Health District 500
Not applicableStudy completedNCT00695097
What this trial is testing

The Effect of Rituximab on the Development of Anti-Donor Antibodies

Who this might be right for
Renal Transplant Rejection
University of California, San Francisco 18
Not applicableActive Not RecruitingNCT05170425
What this trial is testing

LAMBDA 002 (Lung Registry) Study

Who this might be right for
Lung Transplant Rejection
Natera, Inc. 154
Testing effectiveness (Phase 2)Ended earlyNCT05501574
What this trial is testing

An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

Who this might be right for
Lung Transplant Rejection
TFF Pharmaceuticals, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Not applicableStudy completedNCT03873623
What this trial is testing

The TOGETHER Project - Kidney

Who this might be right for
Kidney Transplant Rejection
Mayo Clinic 250
Not applicableUnknownNCT03603548
What this trial is testing

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Who this might be right for
Liver Transplant RejectionImmunosuppression
Medical University of Warsaw 200
Not applicableStudy completedNCT02364674
What this trial is testing

Transplant Optimization Using Functional Imaging

Who this might be right for
Bronchiolitis ObliteransLung Transplant Rejection
FLUIDDA nv 8
Large-scale testing (Phase 3)Study completedNCT00693381
What this trial is testing

Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 152
Not applicableNot Yet RecruitingNCT07145944
What this trial is testing

To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation

Who this might be right for
Kidney Transplant Failure and RejectionTransplantation, KidneyKidney Transplant Dysfunction
Tongji Hospital 500
Post-approval studies (Phase 4)Study completedNCT00656695
What this trial is testing

Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation

Who this might be right for
End Stage Renal DiseaseRenal Transplantation
Imam Khomeini Hospital 208
Large-scale testing (Phase 3)Ended earlyNCT00151632
What this trial is testing

Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation

Who this might be right for
Evidence of Liver Transplantation
Rennes University Hospital 195
Next Page